Novo ready to turn tables on Sanofi (Reuters, 10 May 2011)

11 May 2011


Danish pharmaceutical giant Novo Nordisk will soon be seeking US, European, Japanese and Chinese approval for its new long-lasting insulin product degludec.

Full article


Related Topics

Adrenal Diabetes Metabolism Obesity Cardiovascular Bone Endocrine-Disrupting Chemicals Endocrine-Related Cancer Neuroendocrinology Reproduction Steroid and Steroidogenesis Thyroid

Share this story